抄録
Allergic diseases such as bronchial asthma and atopic dermatitis develop by a combination of genetic and environmental factors. Recently treatment / management guidelines on bronchial asthma and many other disorders have been published, and they are utilized in clinical practice. However, the clinical features of the patients and the causes of the diseases vary. Therefore, personalized medical care (tailor-made medicine) is necessary for the improvement of QOL.
We described the current position of Japanese and Chinese medicine in regard to tailor-made medicine from the viewpoint of allergic disorders, including the results of research concerning genome and post-genome factors (pharmacogenomics, pharmacoprotemics and pharmacometabonomics) by the authors.
